IGM Biosciences Inc
NASDAQ:IGMS

Watchlist Manager
IGM Biosciences Inc Logo
IGM Biosciences Inc
NASDAQ:IGMS
Watchlist
Price: 1.18 USD -3.28%
Market Cap: 70.9m USD

Wall Street
Price Targets

IGMS Price Targets Summary
IGM Biosciences Inc

Wall Street analysts forecast IGMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IGMS is 1.98 USD with a low forecast of 0.76 USD and a high forecast of 3.15 USD.

Lowest
Price Target
0.76 USD
36% Downside
Average
Price Target
1.98 USD
67% Upside
Highest
Price Target
3.15 USD
167% Upside
IGM Biosciences Inc Competitors:
Price Targets
2696
Shanghai Henlius Biotech Inc
24% Downside
CDNA
CareDx Inc
51% Upside
TWST
Twist Bioscience Corp
53% Upside
4584
Kidswell Bio Corporation
31% Upside
CSL
CSL Ltd
35% Upside
TLX
Telix Pharmaceuticals Ltd
35% Upside
688331
RemeGen Co Ltd
25% Downside
IMMU
Mendus AB (publ)
260% Upside

Revenue
Forecast

Revenue Estimate
IGM Biosciences Inc

The compound annual growth rate of IGM Biosciences Inc's revenue for the next 3 years is 78%.

N/A
Past Growth
78%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IGM Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
IGM Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IGMS's stock price target?
Price Target
1.98 USD

According to Wall Street analysts, the average 1-year price target for IGMS is 1.98 USD with a low forecast of 0.76 USD and a high forecast of 3.15 USD.

What is IGM Biosciences Inc's Revenue forecast?
Projected CAGR
78%

The compound annual growth rate of IGM Biosciences Inc's revenue for the next 3 years is 78%.

Back to Top